Research Summary
Oral diabetes medicine encompasses a range of medications taken by mouth to manage blood sugar levels in individuals with diabetes. Primarily used for type 2 diabetes, these medications work through various mechanisms to regulate glucose levels in the body. Some oral diabetes medicines stimulate insulin production, enhance insulin sensitivity in cells, reduce glucose absorption from the intestines, or decrease glucose production in the liver. Common classes of oral diabetes medicines include biguanides, sulfonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors, and meglitinides. Often prescribed in combination with lifestyle changes such as diet and exercise, oral diabetes medicines play a crucial role in diabetes management, helping individuals achieve and maintain optimal blood sugar control to prevent complications and improve overall health.
According to DIResearch's in-depth investigation and research, the global Oral Diabetes Medicine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Oral Diabetes Medicine include Sanofi, Biocon, Boehringer Ingelheim, Merck & Co., Johnson & Johnson, Novartis, Novo Nordisk, Takeda, AstraZeneca, Huadong Medicine, Eli Lilly and Company, Deyuan Pharmaceutical, Hengrui Medicine etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Oral Diabetes Medicine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Oral Diabetes Medicine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Oral Diabetes Medicine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oral Diabetes Medicine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Oral Diabetes Medicine Include:
Sanofi
Biocon
Boehringer Ingelheim
Merck & Co.
Johnson & Johnson
Novartis
Novo Nordisk
Takeda
AstraZeneca
Huadong Medicine
Eli Lilly and Company
Deyuan Pharmaceutical
Hengrui Medicine
Oral Diabetes Medicine Product Segment Include:
DPP-4
GLP-1
SGLT-2
Oral Diabetes Medicine Product Application Include:
Type 1 Diabetes
Type 2 Diabetes
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Oral Diabetes Medicine Industry PESTEL Analysis
Chapter 3: Global Oral Diabetes Medicine Industry Porter's Five Forces Analysis
Chapter 4: Global Oral Diabetes Medicine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Oral Diabetes Medicine Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Oral Diabetes Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Oral Diabetes Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Oral Diabetes Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Oral Diabetes Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Oral Diabetes Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Oral Diabetes Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Oral Diabetes Medicine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Oral Diabetes Medicine Market Overview 1.1 Product Definition and Statistical Scope 1.2 Oral Diabetes Medicine Product by Type 1.2.1 Global Oral Diabetes Medicine Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 DPP-4 1.2.3 GLP-1 1.2.4 SGLT-2 1.3 Oral Diabetes Medicine Product by Application 1.3.1 Global Oral Diabetes Medicine Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Type 1 Diabetes 1.3.3 Type 2 Diabetes 1.4 Global Oral Diabetes Medicine Market Revenue and Sales Analysis 1.4.1 Global Oral Diabetes Medicine Market Size Analysis (2019-2030) 1.4.2 Global Oral Diabetes Medicine Market Sales Analysis (2019-2030) 1.4.3 Global Oral Diabetes Medicine Market Sales Price Trend Analysis (2019-2030) 1.5 Oral Diabetes Medicine Market Development Status and Trends 1.5.1 Oral Diabetes Medicine Industry Development Status Analysis 1.5.2 Oral Diabetes Medicine Industry Development Trends Analysis 2 Oral Diabetes Medicine Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Oral Diabetes Medicine Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Oral Diabetes Medicine Market Analysis by Regions 4.1 Oral Diabetes Medicine Overall Market: 2023 VS 2024 VS 2030 4.2 Global Oral Diabetes Medicine Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Oral Diabetes Medicine Revenue and Market Share by Region (2019-2024) 4.2.2 Global Oral Diabetes Medicine Revenue Forecast by Region (2025-2030) 4.3 Global Oral Diabetes Medicine Sales and Forecast Analysis (2019-2030) 4.3.1 Global Oral Diabetes Medicine Sales and Market Share by Region (2019-2024) 4.3.2 Global Oral Diabetes Medicine Sales Forecast by Region (2025-2030) 4.4 Global Oral Diabetes Medicine Sales Price Trend Analysis (2019-2030) 5 Global Oral Diabetes Medicine Market Size by Type and Application 5.1 Global Oral Diabetes Medicine Market Size by Type 5.1.1 Global Oral Diabetes Medicine Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Oral Diabetes Medicine Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Oral Diabetes Medicine Market Size by Application 5.2.1 Global Oral Diabetes Medicine Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Oral Diabetes Medicine Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Oral Diabetes Medicine Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Oral Diabetes Medicine Market Size by Type 6.3.1 North America Oral Diabetes Medicine Sales by Type (2019-2030) 6.3.2 North America Oral Diabetes Medicine Revenue by Type (2019-2030) 6.4 North America Oral Diabetes Medicine Market Size by Application 6.4.1 North America Oral Diabetes Medicine Sales by Application (2019-2030) 6.4.2 North America Oral Diabetes Medicine Revenue by Application (2019-2030) 6.5 North America Oral Diabetes Medicine Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Oral Diabetes Medicine Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Oral Diabetes Medicine Market Size by Type 7.3.1 Europe Oral Diabetes Medicine Sales by Type (2019-2030) 7.3.2 Europe Oral Diabetes Medicine Revenue by Type (2019-2030) 7.4 Europe Oral Diabetes Medicine Market Size by Application 7.4.1 Europe Oral Diabetes Medicine Sales by Application (2019-2030) 7.4.2 ? Europe Oral Diabetes Medicine Revenue by Application (2019-2030) 7.5 Europe Oral Diabetes Medicine Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Oral Diabetes Medicine Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Oral Diabetes Medicine Market Size by Type 8.3.1 China Oral Diabetes Medicine Sales by Type (2019-2030) 8.3.2 China Oral Diabetes Medicine Revenue by Type (2019-2030) 8.4 China Oral Diabetes Medicine Market Size by Application 8.4.1 China Oral Diabetes Medicine Sales by Application (2019-2030) 8.4.2 China Oral Diabetes Medicine Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Oral Diabetes Medicine Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Oral Diabetes Medicine Market Size by Type 9.3.1 APAC (excl. China) Oral Diabetes Medicine Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Oral Diabetes Medicine Revenue by Type (2019-2030) 9.4 APAC (excl. China) Oral Diabetes Medicine Market Size by Application 9.4.1 APAC (excl. China) Oral Diabetes Medicine Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Oral Diabetes Medicine Revenue by Application (2019-2030) 9.5 APAC (excl. China) Oral Diabetes Medicine Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Oral Diabetes Medicine Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Oral Diabetes Medicine Market Size by Type 10.3.1 Latin America Oral Diabetes Medicine Sales by Type (2019-2030) 10.3.2 Latin America Oral Diabetes Medicine Revenue by Type (2019-2030) 10.4 Latin America Oral Diabetes Medicine Market Size by Application 10.4.1 Latin America Oral Diabetes Medicine Sales by Application (2019-2030) 10.4.2 Latin America Oral Diabetes Medicine Revenue by Application (2019-2030) 10.5 Latin America Oral Diabetes Medicine Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Oral Diabetes Medicine Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Oral Diabetes Medicine Market Size by Type 11.3.1 Middle East & Africa Oral Diabetes Medicine Sales by Type (2019-2030) 11.3.2 Middle East & Africa Oral Diabetes Medicine Revenue by Type (2019-2030) 11.4 Middle East & Africa Oral Diabetes Medicine Market Size by Application 11.4.1 Middle East & Africa Oral Diabetes Medicine Sales by Application (2019-2030) 11.4.2 Middle East & Africa Oral Diabetes Medicine Revenue by Application (2019-2030) 11.5 Middle East & Africa Oral Diabetes Medicine Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Oral Diabetes Medicine Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Oral Diabetes Medicine Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Oral Diabetes Medicine Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Oral Diabetes Medicine Average Sales Price by Manufacturers (2020-2024) 12.2 Oral Diabetes Medicine Competitive Landscape Analysis and Market Dynamic 12.2.1 Oral Diabetes Medicine Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Sanofi 13.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Sanofi Oral Diabetes Medicine Product Portfolio 13.1.3 Sanofi Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Biocon 13.2.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Biocon Oral Diabetes Medicine Product Portfolio 13.2.3 Biocon Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Boehringer Ingelheim 13.3.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Boehringer Ingelheim Oral Diabetes Medicine Product Portfolio 13.3.3 Boehringer Ingelheim Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Merck & Co. 13.4.1 Merck & Co. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Merck & Co. Oral Diabetes Medicine Product Portfolio 13.4.3 Merck & Co. Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Johnson & Johnson 13.5.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Johnson & Johnson Oral Diabetes Medicine Product Portfolio 13.5.3 Johnson & Johnson Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Novartis 13.6.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Novartis Oral Diabetes Medicine Product Portfolio 13.6.3 Novartis Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Novo Nordisk 13.7.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Novo Nordisk Oral Diabetes Medicine Product Portfolio 13.7.3 Novo Nordisk Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Takeda 13.8.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Takeda Oral Diabetes Medicine Product Portfolio 13.8.3 Takeda Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 AstraZeneca 13.9.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 AstraZeneca Oral Diabetes Medicine Product Portfolio 13.9.3 AstraZeneca Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.10 Huadong Medicine 13.10.1 Huadong Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Huadong Medicine Oral Diabetes Medicine Product Portfolio 13.10.3 Huadong Medicine Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.11 Eli Lilly and Company 13.11.1 Eli Lilly and Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Eli Lilly and Company Oral Diabetes Medicine Product Portfolio 13.11.3 Eli Lilly and Company Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.12 Deyuan Pharmaceutical 13.12.1 Deyuan Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Deyuan Pharmaceutical Oral Diabetes Medicine Product Portfolio 13.12.3 Deyuan Pharmaceutical Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.13 Hengrui Medicine 13.13.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Hengrui Medicine Oral Diabetes Medicine Product Portfolio 13.13.3 Hengrui Medicine Oral Diabetes Medicine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Oral Diabetes Medicine Industry Chain Analysis 14.2 Oral Diabetes Medicine Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Oral Diabetes Medicine Typical Downstream Customers 14.4 Oral Diabetes Medicine Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support